| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $692.5M | +38.5% |
| Cost of Revenue | $19.4M | -7.4% |
| R&D Expense | $31.5M | +6.6% |
| SG&A Expense | $34.1M | +12.6% |
| Operating Income | $58.3M | +83.7% |
| Pre-tax Income | $61.8M | +81.8% |
| Income Tax | -$37.5M | -2138.5% |
| Net Income | $99.3M | +208.7% |
| EPS (Basic) | $2.75 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $171.4M | +67.8% |
| Accounts Receivable | $75.1M | +22.5% |
| Current Assets | $256.3M | +49.2% |
| Total Assets | $326.9M | +55.3% |
| Current Liabilities | $87.2M | +20.1% |
| Total Liabilities | $88.9M | +18.2% |
| Stockholders' Equity | $238.0M | +75.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.4M | +43.3% |
| Investing Cash Flow | -$5.1M | -22.9% |
| Financing Cash Flow | -$21.1M | -1334.0% |
| +198.9% |
| EPS (Diluted) | $2.63 | +198.9% |